Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Bedminster, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Intra-Cellular Therapies, Inc. has filed 1,007 SEC EDGAR filings since 08 Feb 2013

SEC filing history

Showing 801-825 of 1,000 matching filings.

Per page
25
Current page
33
4

FORM 4 SUBMISSION

Filing date
02 Jul 2015
Reporting date
30 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jul 2015
Reporting date
30 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jul 2015
Reporting date
30 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36274

FORM 8-K

Filing date
24 Jun 2015
Reporting date
23 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - ROBERT VAN NOSTRAND

Filing date
22 Jun 2015
Reporting date
16 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - RORY RIGGS

Filing date
22 Jun 2015
Reporting date
16 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - JOEL S. MARCUS

Filing date
22 Jun 2015
Reporting date
16 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - RICHARD LERNER, M.D.

Filing date
22 Jun 2015
Reporting date
16 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - CHRISTOPHER ALAFI, PH.D.

Filing date
22 Jun 2015
Reporting date
16 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-205070

S-8

Filing date
18 Jun 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36274

FORM 8-K

Filing date
18 Jun 2015
Reporting date
16 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36274

8-K

Filing date
15 Jun 2015
Reporting date
15 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - LAWRENCE P. WENNOGLE, PH.D.

Filing date
09 Jun 2015
Reporting date
08 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-204509

EFFECT filing

Filing date
05 Jun 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
03 Jun 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
03 Jun 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-36274

CT ORDER filing

Filing date
29 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-204509

FORM S-3

Filing date
28 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36274

FORM 8-K

Filing date
28 May 2015
Reporting date
28 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - LAWRENCE P. WENNOGLE, PH.D.

Filing date
20 May 2015
Reporting date
19 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36274

FORM 8-K

Filing date
19 May 2015
Reporting date
18 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36274

DEFA14A

Filing date
05 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36274

8-K

Filing date
30 Apr 2015
Reporting date
30 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36274

DEF 14A

Filing date
28 Apr 2015
Reporting date
16 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .